✦ LIBER ✦

Dose-Dependent Development of Depressive Symptoms During Adjuvant Interferon-α Treatment of Patients With Malignant Melanoma

✍ Scribed by Astrid Friebe; Martin Horn; Folkhart Schmidt; Gesa Janssen; Monika-H. Schmid-Wendtner; Matthias Volkenandt; Axel Hauschild; Charlie H. Goldsmith; Martin Schaefer

Book ID: 117199744
Publisher: American Psychiatric Publishing Inc
Year: 2010
Tongue: English
Weight: 125 KB
Volume: 51
Category: Article
ISSN: 1545-7206
DOI: 10.1016/s0033-3182(10)70738-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correlation between sICAM-1 and depressi

Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-α

✍ Martin Schaefer; Martin Horn; Folkhard Schmidt; Monika H. Schmid-Wendtner; Matth 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 161 KB

P.2.g.016 Depression during low-dose int

P.2.g.016 Depression during low-dose interferon alpha treatment in patients with malignant melanoma

✍ S. Heinze; S. Rötzer; M. Volkenandt; M. Schäfer 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

576 Early detection of depressive sympto

576 Early detection of depressive symptoms during treatment with pegylated interferon α-2 and ribavirin in euthymic chronic hepatitis C patients

✍ P.E. Golstein; F. Oswalde; J. Mendlewicz; J. Deviere; M. Adler 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Recombinant interferon α-2a in combinati

Recombinant interferon α-2a in combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of long-term responding patients

✍ Ilan G. Ron; Moshe J. Inbar; Mordechai Gutman; Ofer Merimsky; Samario Chaitchik 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 987 KB

Immunomodulatory effects of high-dose an

Immunomodulatory effects of high-dose and low-dose interferon α2b in patients with high-risk resected melanoma : The E2690 laboratory corollary of Intergroup Adjuvant Trial E1690

✍ John M. Kirkwood; Thomas Richards; Hassane M. Zarour; Jeffrey Sosman; Marc Ernst 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

## Background: The clinical antitumor activity of recombinant interferon alpha2b (ifnalpha2b) has been well documented in patients with advanced and high-risk melanoma; however, its mechanism of action remains conjectural. trial e2690 evaluated the immunomodulatory effects of ifnalpha2b in vivo dur

Changes in Peripheral Blood Level of Reg

Changes in Peripheral Blood Level of Regulatory T cells in Patients with Malignant Melanoma During Treatment with Dendritic Cell Vaccination and Low-dose IL-2

✍ J. Bjoern; M. K. Brimnes; M. H. Andersen; P. thor Straten; I. M. Svane 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 600 KB